Re-irradiation of painful bone metastases: a further analysis of the Dutch Bone Metastasis Study

Linden, Yvette M. van der; Lok, Judith J.; Steenland, Elsbeth; Martijn, Hendrik; Marijnen, Corrie A.M.; Leer, J.W.H.

doi:10.1016/s0360-3016(03)01040-x

Cited by 7 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Dutch Bone Metastases Study [11] was re-analyzed to separate the response to initial treatment from the response to re-treatment. Van der Linden presented the results at the 2003 ASTRO meeting [28]. The majority of the 173 patients re-irradiated received single fraction 8 Gy as the initial treatment.…”

Section: Discussionmentioning

confidence: 99%

Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases – an evidence-based practice guideline

Wu¹,

et al. 2004

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases – an evidence-based practice guideline

Wu¹,

et al. 2004

View full text Add to dashboard Cite

show abstract

“…This treatment is less complex and has better survival rates than surgical treatment of actual pathological fractures (Laitinen et al, 2012;Mavrogenis et al, 2012;Ratasvuori et al, 2013). Lesions that do not jeopardise the mechanical integrity of the bone are treated conservatively with (a combination of) radiation therapy, analgesics, chemotherapy, hormonal therapy or bisphosphonates, with the aim to relieve pain ( Van der Linden, 2005). However, it turns out to be extremely difficult, if not impossible, to assess clinical fracture risks based on conventional X-rays or CT images.…”

Section: Introductionmentioning

confidence: 99%

Towards clinical application of biomechanical tools for the prediction of fracture risk in metastatic bone disease

Derikx

Tanck²

2015

Journal of Biomechanics

View full text Add to dashboard Cite

Current clinical practice lacks an accurate predictor for the pathological fracture risk in metastatic bone disease, but biomechanical tools are under development to improve these predictions. In this paper we explain the limitations of currently used clinical guidelines and provide an overview of more objective and quantitative approaches that have been proposed for fracture risk assessment in metastatic bone disease. Currently, such mechanical models are as sensitive and specific as clinical guidelines, but there are a number of opportunities to further improve their predictive capacity. Hence, they are a promising tool to decrease the numbers of over- and undertreated patients.

show abstract

Chinese expert consensus statement on clinical diagnosis and treatment of malignant tumor bone metastasis and bone related diseases

Jiang

Zhang

et al. 2010

Chin. -Ger. J. Clin. Oncol.

View full text Add to dashboard Cite

Clinical diagnosis and treatment of malignant tumor bone metastases OverviewBone is the most common place of metastases in advanced malignant diseases. Constant improvement in the treatment of malignant tumors has resulted in prolonged survival time, and so as an increased incidence of osseous metastases and skeletal complications. Malignant skeletal metastases are commonly found in patients with breast

show abstract

Re-irradiation of painful bone metastases: a further analysis of the Dutch Bone Metastasis Study

Cited by 7 publications

References 0 publications

Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases – an evidence-based practice guideline

Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases – an evidence-based practice guideline

Towards clinical application of biomechanical tools for the prediction of fracture risk in metastatic bone disease

Chinese expert consensus statement on clinical diagnosis and treatment of malignant tumor bone metastasis and bone related diseases

Contact Info

Product

Resources

About